While boosting immune function is essential for tumor elimination, it is still unclear whether dysregulation of fumarate hydratase (FH) expression or function in ccRCC affects tumor immune evasion or PD-L1 expression. This evidence concerns the gene FH and nonpapillary renal cell carcinoma.